AquaBounty Technologies Inc
AQB
NASDAQ
Biotechnology
$1.49
USD
-0.02 (-1.00%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $7.21M
Volume 273.3K
Revenue
$0
TTM
— YoY
Gross Margin
—
TTM
— YoY
Net Income
$-18.35M
TTM
+79.7%
YoY
Operating Cash Flow
$-7.18M
TTM
+20.6%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
YoY Growth | — | — | — | — | — |
Cost of Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, General & Administrative | 1.2 | 1.4 | -0.7 | 0.6 | 0.8 |
Other Operating Expenses | 0.0 | 0.1 | -1.3 | 0.0 | 0.0 |
Total Operating Expenses | 1.2 | 1.5 | -2.0 | 0.6 | 0.8 |
Operating Income | -1.2 | -1.5 | 2.0 | -0.6 | -0.8 |
EBITDA | -1.2 | -1.4 | 0.7 | -0.6 | -0.8 |
Other Income / Expense | -0.0 | -0.0 | -0.0 | -0.0 | -0.0 |
Total Other Income / Expense | -0.0 | -0.0 | 0.0 | -0.3 | -0.5 |
Income Before Income Taxes | -1.2 | -1.5 | 2.0 | -0.9 | -1.3 |
Income Taxes | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Net Income | -3.4 | -1.4 | -14.1 | -1.2 | -1.6 |
Consolidated Net Income / Loss | -3.4 | -1.4 | -14.1 | -1.2 | -1.6 |
Net Income Attributable to Common Shareholders | -3.4 | -1.4 | -14.1 | -1.2 | -1.6 |
Basic EPS | -$0.87 | -$0.36 | -$3.65 | -$0.26 | -$0.32 |
Diluted EPS | -$0.87 | -$0.36 | -$3.65 | -$0.26 | -$0.32 |
Basic Shares Outstanding | 3.9M | 3.9M | 3.9M | 4.6M | 5.1M |
Diluted Shares Outstanding | 3.9M | 3.9M | 3.9M | 4.6M | 5.1M |